fbpx

Vaccines

Yellow fever
  • Stamaril
  • Single dose vaccine valid for 10 years
  • Valid for life after second dose

Read more about Yellow Fever

Diphtheria/Tetanus/Pertussis/Polio
  • Adacel Quadra
  • Four in one vaccine covering all abovementioned diseases
  • Recommended booster as an adult

Read more about Polio
Read more about Tetanus
Read more about Pertussis
Read more about Diphtheria

Diphtheria/Tetanus/Pertussis
  • Boosterix
  • Three in one vaccine covering all abovementioned diseases
  • Recommended booster as an adult

Read more about Tetanus
Read more about Pertussis
Read more about Diphtheria

Typhoid
  • Typhim
  • Single dose vaccination provides cover for a period of 3 to 5 years.

Read more about Typhoid

Hep A and B
  • Twinrix (2 in one combination vaccine)
  • 3 dose regimen within one year provides lifelong protection

Read more about Hepatitis-A
Read more about Hepatitis-B

Meningococcal meningitis
  • Menactra
  • Travellers to areas affected by meningococcal outbreaks should be vaccinated as well as travellers to Saudi Arabia for the Hajj and Umrah. Also recommended for university and hostel accommodation residents.
  • Vaccines are available against serogroups A, C, W 135 and Y (quadrivalent)
  • Single dose provides 5 year protection, boosting recommended

Read more about Meningococcal Meningitis

Paediatric Hep A
  • Avaxim Junior
  • Due to lack of availability of the adult dosage the paediatric vaccine can be used (two paediatric doses = one adult dose)
  • Generally, one single vaccine provides protection within 2 to 4 weeks which lasts for approximately 6 months to 1 year. A single booster dose will maintain the protection for at least a further 10 years.

Read more about Hepatitis A

Hep B
  • Engerix B
  • An initial vaccine with two booster doses administered over a six month period is required for full immunity.

Read more about Hep B

Rabies vaccine
  • Verorab
  • Pre-exposure vaccination which consists of two doses given 7 days apart will protect an individual who comes into contact with a potentially rabid animal and will allow for enough time to get post exposure prophylaxis without the need for rabies immunoglobin which is not readily available.
  • The same vaccine is used if one is exposed to a potentially rabid animal.

Read more about Rabies

Rabies immunoglobulin
  • Rabigam
  • This vaccine is indicated for an individual who comes into contact with a potentially rabid animal with a category 3 exposure. RIG is derived from immunised human donors and is in short supply.

Read more about Rabies

Tetanus
  • Tetavax
  • Available as a single preparation or as part of the 4 in 1 Adacel Quadra
  • One dose provides protection for 10 years, however a booster is recommended if an exposure occurs 5 or more years after the initial dose.

Read more about Tetanus

Pneumococcal disease
  • Prevenar (PCV13)
  • Indicated for individuals with splenic dysfunction, sickle cell disease, immune compromise, chronic lung, heart or liver disease, alcoholism, age over 65 and all smokers regardless of age
  • Pneumovax
  • Recommended as a booster one year after receiving Prevenar; should give lifelong protection but a booster can be administered for high-risk individuals after 5 years
MMR (measles/mumps/rubella)
  • Priorix
  • Part of the childhood vaccine programme; however, a booster is indicated at age 12 and for university and hostel accommodation residents as well as women who are planning to fall pregnant.
Influenza vaccine
  • Vaxigrip Tetra
  • Recommended to all individuals over 6 months of age on a yearly basis. Released yearly based on the strains circulating in the population at the time and what is predicted to affect each hemisphere in the forthcoming winter.
Varicella
  • Chickenpox
    • Varilrix
    • Recommended for children and university hostel residents or anyone staying in shared accommodation
  • Shingles
    • Zostavax – No longer available in South Africa (live vaccine)
      • Recommended for people who have had chicken pox to prevent the development of shingles
      • Risk for developing shingles increases with age, chronic conditions and immune compromise
    • Shingrix (killed vaccine) – Section 21/off label use in South Africa
      • Recombinant shingles vaccine is recommended for adults 50 years and older and adults with immune compromise
      • The Shingrix vaccine is a 2-dose regimen
      • The advantage of the recombinant vaccine is that it is not a live vaccine and can therefore be given to organ transplant recipients and severely immune compromised patients who cannot received a live vaccine
HPV (human papilloma virus)
  • Gardasil
  • Protects against human papilloma virus types 6,11, 16 and 18 (quadrivalent) which cause cervical cancer
  • Recommended to girls over the age of 9; given in 3 doses within a 6-month period